113 related articles for article (PubMed ID: 3512465)
1. Comparative effects of indomethacin and proglumetacin on 6-oxo-PGF1 alpha released ex vivo by rat gastric mucosa.
Conti P; Alesse E; Cifone MG
Int J Tissue React; 1986; 8(1):31-4. PubMed ID: 3512465
[TBL] [Abstract][Full Text] [Related]
2. Cytoprotection and 6-keto-prostaglandin-F1 alpha.
Bálint GA; Varró V
Acta Physiol Hung; 1983; 61(4):233-5. PubMed ID: 6359818
[TBL] [Abstract][Full Text] [Related]
3. Interaction between prostacyclin and colchicine on the gastric mucosa of rat in different experimental ulcer models.
Karácsony G; Bálint GA; Herke P; Varró V
Acta Physiol Hung; 1986; 68(1):45-9. PubMed ID: 3529819
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the ulcerogenicity of indomethacin and the gastric secretion in verapamil-treated rats.
Mirossay L; Nicák A; Kohút A
Physiol Bohemoslov; 1988; 37(6):503-6. PubMed ID: 2976510
[TBL] [Abstract][Full Text] [Related]
5. Investigations of indomethacin-induced gastric ulcer in rats.
Kapui Z; Boér K; Rózsa I; Blaskó G; Hermecz I
Arzneimittelforschung; 1993 Jul; 43(7):767-71. PubMed ID: 8369011
[TBL] [Abstract][Full Text] [Related]
6. Structural damage and changes in eicosanoid metabolites in the gastric mucosa of rats and pigs induced by anti-inflammatory drugs of varying ulcerogenicity.
Rainsford KD
Int J Tissue React; 1986; 8(1):1-14. PubMed ID: 3949439
[TBL] [Abstract][Full Text] [Related]
7. [Reduced ulcerogenic effect after treatment with indomethacin combined with diflunisal in rats].
Conti P; Continenza MA; Cifone MG; Bruno G; Alesse E
Boll Soc Ital Biol Sper; 1980 Apr; 56(8):833-8. PubMed ID: 7448080
[TBL] [Abstract][Full Text] [Related]
8. Predominance of prostaglandin D2 and I2 in the rat gastric mucosa--analysis by high-performance liquid chromatography.
Kinoshita T; Nimura Y; Shionoya S; Goto H; Ozawa T
Biochem Int; 1987 Feb; 14(2):303-9. PubMed ID: 3555501
[TBL] [Abstract][Full Text] [Related]
9. FCE 20700, a cytoprotective PGE2 derivative, does not interfere with the antiinflammatory activity of indomethacin.
Ceserani R; Arrigoni C; Mizzotti B; Tremolada L; Ferrari M; Buttinoni A
Int J Tissue React; 1983; 5(4):349-51. PubMed ID: 6689489
[TBL] [Abstract][Full Text] [Related]
10. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat.
Whittle BJ
Gastroenterology; 1981 Jan; 80(1):94-8. PubMed ID: 6778761
[TBL] [Abstract][Full Text] [Related]
11. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological studies on proglumetacin maleate, a new non-steroidal anti-inflammatory drug. (3) Damaging effects on the gastrointestinal tract].
Ono N; Yamasaki Y; Yamamoto N; Sunami A; Miyake H
Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):205-13. PubMed ID: 3098653
[TBL] [Abstract][Full Text] [Related]
13. Gastric antigen challenge releases gastrin and eicosanoids and protects against ethanol.
Bacha EA; Fernandez ED; Peskar BM; Stroff T; Enders G; Krämling HJ
J Surg Res; 1997 Jun; 70(1):69-74. PubMed ID: 9228931
[TBL] [Abstract][Full Text] [Related]
14. Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa.
Takeuchi K; Tanaka A; Kato S; Aihara E; Amagase K
J Pharmacol Exp Ther; 2007 Sep; 322(3):903-12. PubMed ID: 17578900
[TBL] [Abstract][Full Text] [Related]
15. Gastric mucosal prostaglandin generation in rats with stress ulcer.
Basso N; Materia A; Forlini A; Rossi P; Jaffe BM
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():383-7. PubMed ID: 6221618
[No Abstract] [Full Text] [Related]
16. The effect of tiaprofenic acid and indomethacin on vascular prostacyclin and platelet thromboxane A2 production.
Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
Pharmatherapeutica; 1985; 4(4):260-5. PubMed ID: 3903790
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activity and toxicity of apyramide: comparison with non-steroidal anti-inflammatory agents.
Sauvaire D; Michel A; Serrano JJ; Richard M
Drugs Exp Clin Res; 1987; 13(5):247-52. PubMed ID: 3500027
[TBL] [Abstract][Full Text] [Related]
19. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
20. Role of prostaglandins in mucus synthesis in rat gastric mucosa.
Quadros E; Wilson DE
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():767-70. PubMed ID: 1825408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
